Transparency Market Research holds a major resource pool of market intelligence reports in the
global pharmaceutical industry. One of the reports in this database is the report titled “Cancer
Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast
2015 – 2023.” This report provides its users with key details necessary to derive an accurate
market forecast for a fruitful strategic venture into the global market for cancer hormone therapy.
The key driver of the global cancer hormone therapy market is the increasing prevalence of
cancer. Multiple reasons are accountable for this rise in the number of cancer patients across the
globe, including the changes in lifestyle, the increasing use of carcinogens, the rise in the number
of cigarette smokers, the increase in awareness about the benefits of early diagnosis of cancer,
and the growing geriatric population.
The increase in awareness about cancer and its diagnosis applies to both physicians as well as
patients. This increase has created a higher scope for growth of alternative therapy procedures for
cancer, including hormone therapy, immunotherapy, and target therapy.
One of the key restraints affecting the global cancer hormone therapy market is the list of side-
effects associated with it. This list includes vaginal dryness, irregular periods, male impotence,
loss of appetite, enlargement of breasts among males, persistent skin rashes, and vaginal spotting.
Download Report Brochure:-
Hormone therapy is considered to be a key aspect of modern medicine for cancer therapy. It
involves modifying the endocrine system in order to administer steroids or inhibitor drugs. The
process is done through exogenous administration and can be used to block the activities of
Surgical intervention is also a part of the global cancer hormone therapy market. This involves
the removal of specific endocrine organs. One such procedure is oophorectomy, which is the
surgical removal of ovaries in the case of ovarian cancer.
Most procedures in the global cancer hormone therapy market are performed in succession to a
hormone receptor test, which allows a physician to estimate the quantity of hormones required to
make the procedure a success.
According to the World Health Organization, the various types of cancer are collectively
responsible for the largest percentage of global morbidity and mortality rates. Nearly 8.2 mn
patients lost their lives to cancer in 2012, a year when 14 mn new cases were registered. Over the
next two decades, this number is expected to increase by 70%. The WHO also cites five risks
involved in human behavior and diet: use of alcohol, use of tobacco, sedentary lifestyles, high
BMI, and low consumption of fruits and vegetables.
The key players in the global cancer hormone therapy market are Pfizer, Inc., QuatRx
Pharmaceuticals, Merck & Co.,Novartis International AG, and AstraZeneca PLC.
Transparency Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight for thousands of decision
makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that
it always reflects the latest trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous primary and secondary research
techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453